Interview conducted by Emily Henderson, B.Sc. Jan 25 2021 Thought Leaders Dr. David BrodyProfessor of NeurologyUniformed Services University In this interview, News-Medical speaks to Dr. David Brody about his latest research that involved discovering nanobodies produced by llamas that could help combat coronavirus. What provoked your research into the ongoing COVID-19 pandemic? We are neuroscientists, so it was a...
UW Medicine scientists are driving a bold, multi-partner experiment to stimulate the repair and regeneration of human kidney cells. A favorable outcome could jump-start a new therapy model for 850 million people worldwide who live with kidney disease. The National Institutes of Health recently announced the project’s funding: $4 million over five years. The study focuses on...
IMAGE: FROM LEFT: LEO HANKE, BEN MURRELL AND GERALD MCINERNEY, RESEARCHERS AT THE DEPARTMENT OF MICROBIOLOGY, TUMOR AND CELL BIOLOGY AT KAROLINSKA INSTITUTET. Researchers at Karolinska Institutet in Sweden have identified a small neutralizing antibody, a so-called nanobody, that has the capacity to block SARS-CoV-2 from entering human cells. The researchers believe this nanobody has...
As the world awaits vaccines to bring the COVID-19 pandemic under control, UC San Francisco scientists have devised a novel approach to halting the spread of SARS-CoV-2, the virus that causes the disease. Led by UCSF graduate student Michael Schoof, a team of researchers engineered a completely synthetic, production-ready molecule that straitjackets the crucial SARS-CoV-2...
Finding holds promise to advance targeted treatment for neurological diseases and cancer CASE WESTERN RESERVE UNIVERSITY Researchers from Case Western Reserve University School of Medicine have found a nanobody that holds promise to advance targeted therapies for a number of neurological diseases and cancer. In a recent study published in Nature Communications, Sahil Gulati, of the Department...
